Molecular Diagnostics
Blood Test for Alzheimer's to Be Developed and Commercialized
A developer and supplier of multiplex protein detection arrays and array-based test kits, and a molecular diagnostics company focused on developing blood-based tests will cooperate to develop and commercialize an Alzheimer's disease detection blood test based on plasma biomarkers. More...30 Apr 2009
In Other News
Large-Scale Cervical Cancer Screening Project Planned for India
Test for Clostridium Difficile Is Rapid and Efficient
Multianalyte Quality Control Introduced for NAT Labs
RT-PCR Assay Detects and Differentiates Parainfluenza Viruses
Determination of Protein Phosphorylation Helps Diagnose Blood Cancers
Prostate Cancer Urine Test Based on Gene Fusion
Cold-PCR Enriches DNA Mutations in Samples
Genotyping Panels Detect Polymorphisms and Gene Variants
Multiplex Mass Spectrometric Immunoassays Will Improve Cancer Diagnosis
Blood Test Will Predict Seriousness of Brain Injuries
Transfusable Blood to Be Made From ESCs
Beckman Coulter Augments Genomic Services with Cogenics Acquisition
Amplified DNA Assays Detect Chlamydia Trachomatis and Neisseria Gonorrhoeae
Cardiac Specific C-Reactive Protein Test Extended Across Multiple Platforms
New TB Test Will Dramatically Cut Diagnosis Time
Molecular-Based Test Will Help Pathologists Diagnose Prostate Cancer
Scientists and Nonprofit Organizations Develop Affordable Diagnostics
Set of Genes Identifies Four Known Breast Cancer Types
New Molecular Assays Test for Human Papillomavirus
Direct Relationship Found Between Two Antibodies and AD Severity
LOAC System Could Revolutionize Point-of-Care Diagnostics
MicroRNA Biomarker Successfully Identifies Squamous Lung Cancer
Noninvasive Prenatal Genetic Screening Tests Are Safer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








